BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27316481)

  • 21. Regional QT Interval Dispersion as an Early Predictor of Reperfusion in Patients with Acute Myocardial Infarction after Fibrinolytic Therapy.
    Dotta G; Fonseca FAH; Izar MCO; Souza MT; Moreira FT; Pinheiro LFM; Barbosa AHP; Caixeta AM; Póvoa RMS; Carvalho AC; Bianco HT
    Arq Bras Cardiol; 2019 Jan; 112(1):20-29. PubMed ID: 30570061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic prediction of the success of coronary reperfusion by intravenous thrombolytic therapy: an experimental study.
    Tomoda H
    Angiology; 1992 Aug; 43(8):631-40. PubMed ID: 1632565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
    Zeymer U; Schröder R; Tebbe U; Molhoek GP; Wegscheider K; Neuhaus KL
    Eur Heart J; 2001 May; 22(9):769-75. PubMed ID: 11350109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of early reperfusion and prediction of left ventricular damage from the course of increased ST values in acute myocardial infarct with thrombolysis].
    Dissmann R; Goerke M; von Ameln H; Rennhak U; Schroeder J; Linderer T; Schröder R
    Z Kardiol; 1993 May; 82(5):271-8. PubMed ID: 8328176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
    Zhao L; Zhao Z; Chen X; Li J; Liu J; Li G;
    Heart Vessels; 2018 May; 33(5):507-512. PubMed ID: 29209778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is arrhythmogenicity related to the speed of reperfusion during thrombolysis for myocardial infarction?
    Gressin V; Gorgels AP; Louvard Y; Lardoux H; Bigelow RH
    Eur Heart J; 1993 Apr; 14(4):516-20. PubMed ID: 7682509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).
    Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M
    Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.
    De Luca G; Suryapranata H; Marino P
    Prog Cardiovasc Dis; 2008; 50(5):352-82. PubMed ID: 18313480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.
    Schröder R; Zeymer U; Wegscheider K; Neuhaus KL
    Eur Heart J; 1999 Nov; 20(21):1563-71. PubMed ID: 10529324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early clinical, electrocardiographic and biological criteria of reperfusion after intravenous fibrinolysis during the acute phase of myocardial infarction].
    Bonnefoy E; Grollier G; Fradin S; Scanu P; Tessier P; Valette B; Foucault JP; Potier JC
    Arch Mal Coeur Vaiss; 1993 Jun; 86(6):857-63. PubMed ID: 8274057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction.
    Kilic S; Kocabas U; Can LH; Yavuzgil O; Çetin M; Zoghi M
    Cardiol J; 2019; 26(2):169-175. PubMed ID: 29512096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The occurrence of sustained (>30 seconds) AIVR and probably early (<2 hours) nonsustained AIVR convey useful information about both early reperfusion and sustained coronary artery patency.
    Tsai SH; Lin YY; Chu SJ; Wu CP
    J Trauma; 2006 Mar; 60(3):687-8. PubMed ID: 16531881
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme.
    Raja DC; Subban V; Victor SM; Joseph G; Thomson VS; Kannan K; Gnanaraj JP; Veerasekar G; Thenpally JG; Livingston N; Nallamothu BK; Alexander T; Mullasari AS
    Indian Heart J; 2017; 69(5):573-579. PubMed ID: 29054179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Jinatongthai P; Kongwatcharapong J; Foo CY; Phrommintikul A; Nathisuwan S; Thakkinstian A; Reid CM; Chaiyakunapruk N
    Lancet; 2017 Aug; 390(10096):747-759. PubMed ID: 28831992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous psoas hematoma in a case of acute myocardial infarction following streptokinase infusion.
    Abhishek BS; Vijay SC; Avanthi V; Kumar B
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S18-S21. PubMed ID: 27751282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).
    Goldstein P; Wiel E
    Minerva Anestesiol; 2005 Jun; 71(6):297-302. PubMed ID: 15886591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm.
    Wang L; Liu H; Zhu C; Gu K; Yang G; Chen H; Ju W; Li M; Zhang F; Yang B; Wang DW; Chen M
    BMC Cardiovasc Disord; 2021 Sep; 21(1):425. PubMed ID: 34496747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of thrombolytic therapy with low doses of streptokinase in acute myocardial infarction].
    Raffo C; Bartolucci J; Corbalán R; Aninat M; Torres H; Prieto JC; Lanas F; Chávez E; Cumsille F; Nazzal C;
    Rev Med Chil; 2006 Oct; 134(10):1249-57. PubMed ID: 17186094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Door to needle time of streptokinase and ST segment resolution assessing the efficacy of reperfusion therapy at Karachi Institute of Heart Diseases.
    Sultana R; Sultana N; Rasheed A; Rasheed Z; Ahmed M; Ishaq M; Samad A
    J Ayub Med Coll Abbottabad; 2010; 22(1):150-3. PubMed ID: 21409930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.